Vaginal Slings Market to Improve at 3.6% CAGR Between 2017 and 2023

Pune, India, August 2019, MRFR Press Release/- Market Research Future has Published a Cooked Research Report on the Global Vaginal Slings Market.

Overview

Vaginal sling procedures are defined as types of surgeries that can help to control stress urinary incontinence. A new report on the global vaginal slings market, published by Market Research Future (MRFR), infers that this market could mark improvement at 3.6 % CAGR between 2017 and 2023. In terms of value, the market can be worth USD 1,459 Mn by the end of the forecast period.

Major market driving factors of the global vaginal slings market include the aging female population, increasing research to discover new urinary incontinence treatment options, rising occurrence of urinary incontinence. However, the complications caused by urinary incontinence surgery and various recent product recall can hinder the market growth.

Market Segmentation

The global vaginal slings market segmentation encompasses end-user, method, and product type. MRFR’s take on the market explores various facets of the market in-depth.

Regarding end-users, this market has been segmented into ambulatory surgery centers, hospitals, urogynecology clinics, and others. The hospitals segment can be worth USD 539.7 Mn by 2023.

In the context of method, the market has been segmented into the retropubic method, single-incision mini method, and transobturator method.

Based on product type, the market has been segmented into mini-slings/single-incision slings, tension-free vaginal tape slings (TVT), transobturator tape slings (TOT), and others. The TVT segment holds the 52% market share in the global vaginal slings market.

Access Report Details @ https://www.marketresearchfuture.com/reports/vaginal-slings-market-7888

Regional Segmentation

A geographical outlining of the global vaginal slings market covers Europe, The Americas (North America & Latin America), Asia Pacific, and the Middle East & Africa (MEA).

During the forecast period, the Americas region is expected to hold the largest market share in the global market due to the increasing awareness and the rising prevalence of urinary incontinence among the female population. Availability of advanced medical facilities in the USA and Canada is also boosting the market growth. Due to this reason, North America is the bigger regional market segment, compared to Latin America.

During the forecast period, the European market is likely to grow substantially due to increased healthcare spending and increasing awareness related to urinary incontinence issues. Due to the reasons the same as The Americas, Western Europe is a bigger regional market segment compared to Eastern Europe. Germany holds a 27% share in the market of Western Europe. Other pressing country-specific markets in this region are France, Italy, Spain, and the UK. An analysis of the remaining countries in Western Europe featured in this report estimates the huge contribution to market revenue from some other countries, along with and a sizable revenue contribution from Eastern Europe.

During the forecast period, the Asia Pacific region can stand as the fastest growing regional market due to the development of new infrastructure to support the healthcare industry and the presence of a large number of research organizations. The largest country-specific markets in this region are Australia, China, India, Japan, and South Korea. An analysis of the remaining countries in the Asia Pacific region featured in this report anticipates the huge contribution to market revenue from some other countries. The MEA region is expected to show the least amount of growth due to the lack of adequate healthcare spending and low per capita income.

Key Players

Major players in the global vaginal slings market include A.M.I. GmbH (Austria), Betatech Medical (Turkey), Boston Scientific Corporation (USA), CL Medical (France), Coloplast Corp (Denmark), Ethicon Inc. (USA), Herniamesh S.r.l. (Italy), and Promedon (Argentina).

Latest Industry News

• Many researchers, including some affiliated with the Newcastle University of UK, have completed a research study after examining the data from 175 clinical trials. The conclusions of this study reveals that although different types of vaginal mesh implant surgery may be effective for treating bladder leaks, the long-term safety and effectiveness of the procedures was not a guarantee. 14 JUNE 2019

• The US Food and Drug Administration (FDA) has ordered medical device companies to halt the sales as well as the distribution of surgical mesh used in surgeries to repair pelvic organ prolapse. 17 APR 2019